Avamere Transitional Care & Rehabilitation – Brighton Opens a Dedicated COVID-19 United

The 50-bed unit at Avamere Transitional Care & Rehabilitation provides a dedicated place for individuals to transition from hospital to home while recovering from the virus, following the recommended 14-day quarantine by the Centers for Disease Control and Prevention.

Avamere Transitional Care & Rehabilitation – Brighton calls this the ABC unit, standing for “Avamere Brighton Cares.”

“Being in the healthcare industry, we have the honor of serving seniors in our local community,” stated Rachel Rodriguez, Interim Administrator at Avamere Transitional Care & Rehabilitation – Brighton. “This is our way of helping those who need us most during this crucial time.”

The unit will feature dedicated full-time occupational, physical, and speech therapists, as well as a unit-dedicated hospice team from Dignity Hospice.

Dr. Shad Grubbs and associate extended providers will work with patients one-on-one in the COVID-19 unit, Avamere’s Medical Director at the Brighton location and Avamere Transitional Care and Rehabilitation – Malley in Northglenn, Colorado.

This dedicated unit is unique for senior care communities in Colorado. In fact, state health officials told Avamere they were a pioneer in Colorado.

But at the heart of it all is a team dedicated to living Avamere’s mission to enhance the life of every person they serve.

“Our altruistic goal is to serve the Denver area, serve the community,” stated Dr. Grubbs.

​Avamere Transitional Care & Rehabilitation – Brighton is accepting patients in Brighton, Colorado, and the surrounding areas.


Other hospital-related news items can be found here.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.